ArticlePharmaceutics2024

A New Heteroleptic Zn(II) Complex with Schiff Bases Sensitizes Triple-Negative Breast Cancer Cells to Doxorubicin and Paclitaxel.

Raiane Aparecida Dos Santos Machado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.